Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

A novel mechanism for mitogen-activated protein kinase localization.

Bind E, Kleyner Y, Skowronska-Krawczyk D, Bien E, Dynlacht BD, Sánchez I.

Mol Biol Cell. 2004 Oct;15(10):4457-66. Epub 2004 Jul 21.

2.

Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif.

Aberg E, Torgersen KM, Johansen B, Keyse SM, Perander M, Seternes OM.

J Biol Chem. 2009 Jul 17;284(29):19392-401. doi: 10.1074/jbc.M109.023283. Epub 2009 May 27.

3.

Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.

Seternes OM, Mikalsen T, Johansen B, Michaelsen E, Armstrong CG, Morrice NA, Turgeon B, Meloche S, Moens U, Keyse SM.

EMBO J. 2004 Dec 8;23(24):4780-91. Epub 2004 Dec 2. Erratum in: EMBO J. 2005 Feb 23;24(4):873.

5.
6.

Scaffolding by ERK3 regulates MK5 in development.

Schumacher S, Laass K, Kant S, Shi Y, Visel A, Gruber AD, Kotlyarov A, Gaestel M.

EMBO J. 2004 Dec 8;23(24):4770-9. Epub 2004 Nov 11.

7.

Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo.

Robinson MJ, Xu Be BE, Stippec S, Cobb MH.

J Biol Chem. 2002 Feb 15;277(7):5094-100. Epub 2001 Dec 6.

8.

Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.

De la Mota-Peynado A, Chernoff J, Beeser A.

J Biol Chem. 2011 Apr 15;286(15):13603-11. doi: 10.1074/jbc.M110.181743. Epub 2011 Feb 11.

9.

Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression.

Julien C, Coulombe P, Meloche S.

J Biol Chem. 2003 Oct 24;278(43):42615-24. Epub 2003 Aug 12.

10.

ERK3 is a constitutively nuclear protein kinase.

Cheng M, Boulton TG, Cobb MH.

J Biol Chem. 1996 Apr 12;271(15):8951-8.

11.

Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.

Déléris P, Trost M, Topisirovic I, Tanguay PL, Borden KL, Thibault P, Meloche S.

J Biol Chem. 2011 Feb 25;286(8):6470-8. doi: 10.1074/jbc.M110.181529. Epub 2010 Dec 22.

13.

The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology.

Brand F, Schumacher S, Kant S, Menon MB, Simon R, Turgeon B, Britsch S, Meloche S, Gaestel M, Kotlyarov A.

Mol Cell Biol. 2012 Jul;32(13):2467-78. doi: 10.1128/MCB.06633-11. Epub 2012 Apr 16.

14.

Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5.

Kant S, Schumacher S, Singh MK, Kispert A, Kotlyarov A, Gaestel M.

J Biol Chem. 2006 Nov 17;281(46):35511-9. Epub 2006 Sep 13.

15.
16.
17.
18.

Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4.

Aberg E, Perander M, Johansen B, Julien C, Meloche S, Keyse SM, Seternes OM.

J Biol Chem. 2006 Nov 17;281(46):35499-510. Epub 2006 Sep 13.

20.

N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.

Coulombe P, Rodier G, Bonneil E, Thibault P, Meloche S.

Mol Cell Biol. 2004 Jul;24(14):6140-50.

Supplemental Content

Support Center